Founded in 2005 Ora Bio Ltd, a biopharmaceutical company, is engaged in the repositioning of existing drugs for second-use applications. nnThe Company is developing its two products, the ORA101 and ORA102, as drugs for non-small cell lung cancer (NSCLC) and age-related macular degeneration (AMD) respectively. Both the company's products are currently in Phase II clinical trials.n
Orabio Headquarter Location
Predict your next investment
The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.
Expert Collections containing Orabio
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Orabio is included in 4 Expert Collections, including Pharma Startups.
Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.
Pharmaceutical and biotechnology companies with cancer therapy drug candidates.
Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.